As the stigma associated with the common cannabinoids CBD & CBG fade, and the mainstream use of the products yields to it being accepted as a “legitimate” part of your healing routine, dosage starts to become a more popular topic. Those dosages begin to be more symptom and condition specific. Baselines begin to emerge and “recommended dosages” become more relevant. This is a natural course as the cannabinoids transform from being associated as a recreational drug and begin to be considered an alternative medicine.
Recent recommendations for doses of CBD for more severe and chronic conditions follows a formula. The baseline, or suggested dosage, is 0.25mg CBD per pound of body weight on a daily basis. This would put a 200 lb person at 50mg CBD daily. Ideally, they would split this dose between morning and evening. And while this dosage is the recommendation many CBD companies continue to offer products at dosages from 8mg to 10mg and make these dosage recommendations unclear and dosages per product are muddled and confusing for many consumers to follow.
Read this article to see medical journal publications and follow the links to learn more about medical studies that have been performed that have influenced this recommended dosage.
Medical Study Findings & CBD Dosage Recommendations
In July 2021 “Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process” outlined dosage recommendations for patients experiencing neuropathic, inflammatory, nociplastic, and mixed pain. In conservative and rapid protocols alike the dosage went as high as 40mg/day or until the patient reached their goals.
In another study published in March 2020 the “Dosage, Efficacy and Saety of Cannabidiol Administration in Adults: A systematic Review of Human Trials” showed promising recommendations for specific conditions. These included anxiety disorders, substance abuse, and other conditions.
Across 11 studies a range of 150mg to 900mg was seen to reduce anxiety.
Among 196 participants, including a small group of acute schizophrenia patients, were administered between 200mg and 800mg per day for 4 weeks. When compared to a similar group using amisulpride, a potent antipsychotic, CBD was as effective in improving psychotic symptoms and associated with marked tolerability and safety, wen compared with amisulpride.
Substance Use Disorder
In a randomized cross-over design trial, inhaled pure CBD over 1 week produced positive effects with regard to nicotine addiction. This was measured by a reduction on the number of cigarettes smoked in a group of healthy smokers willing to quite the habit. While CBD did not show effect on craving symptoms, after overnight tobacco abstinence, single doses of 800mg of CBD reduced the salience and pleasantness of cigarette cues. This indicated that CBD may have a potential effect on motivational aspects of addiction.
As an antiepileptic drug doses ranged from 5mg/kg/day and in some patients reached as high as 2,000mg/day. In patients refractory to conventional anti-seizure drugs and reported a decrease in seizure frequency and severity with the Chalfont seizure severity scale from 80.7 at baseline to 39.2 at 12 weeks. This value remained stable thereafter with a total follow-up at 48 weeks.
As a topical cream for skin disorders from 25/mg to 15mg/day for up to 12 weeks following adverse drug reactions (ADR) following HPV vaccine the introduction of topical CBD applications produced positive results for serious skin inflammatory conditions such as psoriasis, acne and related scars, with no side effects being reported.
As clinical studies continue to report positive results for specific conditions, our team at Natural Blüm will continue to work hard to ensure that this data finds its way to the “Daily Dose.” Subscribe to our social media and newsletter to receive updates.